[
1. Banerjeei S.K., Zoubine M.N., Sarkar D.K., Weston A.P., Shah J.H., Campbell D.R.: 2-Methoxyestradiol blocks estrogen-induced rat pituitary tumor growth and tumor angiogenesis: possible role of vascular endothelial growth factor. Anticancer Res 2000, 20, 2641-2645.
]Search in Google Scholar
[
2. Basini G., Bussolati S., Santini S.E., Bianchi F., Careri M., Mangia A., Musci M., Grasselli F.: Antiangiogenesis in swine ovarian follicle: A potential role for 2- methoxyestradiol. Steroids 2007, 72, 660-665.10.1016/j.steroids.2007.05.002
]Search in Google Scholar
[
3. Basini G., Santini S.E., Grasselli F.: 2-Methoxyestradiol inhibits superoxide anion generation while it enhances superoxide dismutase activity in swine granulosa cells. Ann N Y Acad Sci 2006, 1091, 34-40.10.1196/annals.1378.052
]Search in Google Scholar
[
4. Bianchi F., Mattarozzi M., Careri M., Mangia A., Musci M., Grasselli F., Bussolati S., Basini G.: An SPME-GCMS method using an octadecyl silica fibre for the determination of the potential angiogenesis modulators 17-β estradiol and 2-methoxyestardiol in culture media. Anal Bioanal Chem 2010, 396, 2639-2645.10.1007/s00216-010-3508-z
]Search in Google Scholar
[
5. Bogacka I., Siawrys G., Okrasa S., Kamiński T., Przała J.: The influence of GnRH, oxytocin and vasoactive intestinal peptide on the secretion of -endorphin and production of cAMP and cGMP by porcine pituitary cells in vitro. Anim Reprod Sci 2002, 69, 125-137.10.1016/S0378-4320(01)00176-2
]Search in Google Scholar
[
6. Bourghardt J., Bergstrom G., Krettek A., Sjoberg S., Boren J., Tivesten A.: The endogenous estradiol metabolite 2-methoxyestradiol reduces atherosclerotic lesion formation in female apolipoprotein E - deficient mice. Endocrinology 2007, 148, 4128-4132.10.1210/en.2007-025917446178
]Search in Google Scholar
[
7. Das U.N.: A radical approach to cancer. Med Sci Monit 2002, 8, 79-92.
]Search in Google Scholar
[
8. Fenoy F.J., Hernandez M.E., Hernandez M., Quesada T., Salom M.G.: Acute effects of 2-methoxyestradiol on endothelial aortic NO release in male and ovariectomized female rats. Nitric Oxide 2010, 23, 12-19.10.1016/j.niox.2010.03.00220302966
]Search in Google Scholar
[
9. Hagen T., D’Amico G., Quintero M., Palacios-Callender M., Hollis V., Lam F., Moncada S.: Inhibition of mitochondrial respiration by anticancer agent 2-ME. Biochem Biophys Res Commun 2004, 322, 923-929.10.1016/j.bbrc.2004.07.20415336552
]Search in Google Scholar
[
10. Huang P., Feng L., Oldham E.A., Keating M.J., Plunkett W.: Superoxide dismutase as a target for the selective killing of cancer cells. Nature 2000, 407, 390-395.10.1038/3503014011014196
]Search in Google Scholar
[
11. Kosior-Korzecka U., Bobowiec R.: Effect of leptin, insulin and IGF-I on GnRH-induced LH secretion from porcine pituitary cells in vitro. Bull Vet Inst Pulawy 2007, 51, 439-443.
]Search in Google Scholar
[
12. Kosior-Korzecka U., Bobowiec R.: Leptin effect on nitric oxide and GnRH-induced FSH secretion from ovine pituitary cells in vitro. J Physiol Pharmacol 2006, 57, 637-647.
]Search in Google Scholar
[
13. LaVallee T.M., Zhan X.H., Herbstritt Ch.J., Kough E.C., Green S.J., Pribluda V.S.: 2-Methoxyestradiol inhibits proliferation and induces apoptosis independently of estrogen receptors α and β. Cancer Res 2002, 62, 3691-3697.
]Search in Google Scholar
[
14. Liu Z.J., Zhu B.T.: Concentration-dependent mitogenic and antiproliferative actions of 2-methoxyestradiol in estrogen receptor-positive human breast cancer cells. J Steroid Biochem 2004, 88, 265-275.10.1016/j.jsbmb.2003.12.00315120420
]Search in Google Scholar
[
15. Mueck A.O., Seeger H.: 2-Methoxyestradiol-biology and mechanism of action. Steroids 2010, 75, 625-631.10.1016/j.steroids.2010.02.01620214913
]Search in Google Scholar
[
16. Newman S.P., Foster P.A., Ho Y.T., Day J.M., Raobaikady B., Kasprzyk P.G., Leese M.P., Potter B.V.L., Reed M.J., Purohit A.: The therapeutic potential of a series of orally bioavailable antiangiogenic microtubule disruptors as therapy for hormoneindependent prostate and breast cancers. Br J Cancer 2007, 97, 1673-1682.10.1038/sj.bjc.6604100236028318026194
]Search in Google Scholar
[
17. Pribluda V.S., Gubish E.R., LaVellee T.M., Treston A., Swartz G.M., Green S.J.: 2-Methoxyestradiol: an endogenous antiangiogenic and antiproliferative drug candidate. Cancer Metastasis Rev 2000, 19, 173-179.10.1023/A:1026543018478
]Search in Google Scholar
[
18. Ricker J.L., Chen Z., Yang X.P., Pribluda V.S., Swartz G.M., Van Waes C.: 2-Methoxyestradiol inhibits hypoxia-inducible factor 1α, tumor growth, and angiogenesis and augments paclitaxel efficacy in head and neck squamous cell carcinoma. Clin Cancer Res 2004, 10, 8665-8673.10.1158/1078-0432.CCR-04-139315623651
]Search in Google Scholar
[
19. Shang W., Konidari I., Schomberg D.W.: 2- Methoxyestradiol, an endogenous estradiol metabolite, differentially inhibits granulosa and endothelial cell mitosis: a potential follicular antiangiogenic regulator. Biol Reprod 2001, 65, 622-627.10.1095/biolreprod65.2.62211466234
]Search in Google Scholar
[
20. Schumacher G., Neuhaus P.: The physiological estrogen metabolite 2-methoxyestradiol reduces tumor growth and induces apoptosis in human solid tumors. J Cancer Res Clin Oncol 2001, 127, 405-410.10.1007/s00432000023311469676
]Search in Google Scholar
[
21. Spicer L.J., Walega M.A., Hammond J.M.: Metabolism of [3H]2-hydroxyestradiol by cultured porcine granulosa cells: Evidence for the presence of a catechol-Omethyltransferase pathway and a direct stimulatory effect of 2-methoxyestradiol on progesterone production. Biol Reprod 1987, 36, 562-571.10.1095/biolreprod36.3.5623593828
]Search in Google Scholar
[
22. Zacharia L.C., Jackson E.K., Gillespie D.G., Dubey R. K.: Increased 2-methoxyestradiol production in human coronary versus aortic vascular cells. Hypertension 2001, 37, 658-662.10.1161/01.HYP.37.2.65811230352
]Search in Google Scholar
